BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 20507385)

  • 1. Epidermolysis bullosa acquisita: what's new?
    Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita.
    Remington J; Chen M; Burnett J; Woodley DT
    Curr Dir Autoimmun; 2008; 10():195-205. PubMed ID: 18460887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease.
    Hashimoto T; Ishii N; Ohata C; Furumura M
    J Pathol; 2012 Sep; 228(1):1-7. PubMed ID: 22692770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
    J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
    Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
    Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermolysis bullosa acquisita.
    Kim JH; Kim SC
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1204-13. PubMed ID: 23368767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermolysis bullosa acquisita.
    Gupta R; Woodley DT; Chen M
    Clin Dermatol; 2012; 30(1):60-9. PubMed ID: 22137228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature.
    Mayuzumi M; Akiyama M; Nishie W; Ukae S; Abe M; Sawamura D; Hashimoto T; Shimizu H
    Br J Dermatol; 2006 Nov; 155(5):1048-52. PubMed ID: 17034540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen.
    Sitaru C; Mihai S; Otto C; Chiriac MT; Hausser I; Dotterweich B; Saito H; Rose C; Ishiko A; Zillikens D
    J Clin Invest; 2005 Apr; 115(4):870-8. PubMed ID: 15841176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice.
    Sesarman A; Mihai S; Chiriac MT; Olaru F; Sitaru AG; Thurman JM; Zillikens D; Sitaru C
    Br J Dermatol; 2008 Mar; 158(3):463-71. PubMed ID: 18205879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Epidermolysis bullosa acquisita].
    Hofmann SC; Weidinger A
    Hautarzt; 2019 Apr; 70(4):265-270. PubMed ID: 30887080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita.
    Sitaru AG; Sesarman A; Mihai S; Chiriac MT; Zillikens D; Hultman P; Solbach W; Sitaru C
    J Immunol; 2010 Feb; 184(3):1596-603. PubMed ID: 20038644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermolysis bullosa acquisita associated with epidermal-binding circulating antibodies.
    Wakelin SH; Bhogal B; Black MM; Allen J; Wojnarowska F; Hashimoto T; Farr PM; Swain AF
    Br J Dermatol; 1997 Apr; 136(4):604-9. PubMed ID: 9155969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients.
    Woodley DT; Ram R; Doostan A; Bandyopadhyay P; Huang Y; Remington J; Hou Y; Keene DR; Liu Z; Chen M
    J Invest Dermatol; 2006 Jun; 126(6):1323-30. PubMed ID: 16543893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice.
    Sitaru C; Chiriac MT; Mihai S; Büning J; Gebert A; Ishiko A; Zillikens D
    J Immunol; 2006 Sep; 177(5):3461-8. PubMed ID: 16920988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies.
    Nishida E; Nishio E; Murashima H; Ishii N; Hashimoto T; Morita A
    J Dermatol; 2018 Apr; 45(4):472-474. PubMed ID: 29205468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of experimental epidermolysis bullosa acquisita by immunization with murine collagen VII.
    Sesarman A; Sitaru C
    Methods Mol Biol; 2013; 961():371-87. PubMed ID: 23325658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental models of epidermolysis bullosa acquisita.
    Sitaru C
    Exp Dermatol; 2007 Jun; 16(6):520-31. PubMed ID: 17518993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
    Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
    J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita.
    Kasperkiewicz M; Hirose M; Recke A; Schmidt E; Zillikens D; Ludwig RJ
    Br J Dermatol; 2010 May; 162(5):1064-70. PubMed ID: 20222918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.